Cargando…
Superior Efficacy and Safety of a Nonemulsive Variant of the NGcGM3/VSSP Vaccine in Advanced Breast Cancer Patients
NGcGM3 ganglioside is a tumor-specific antigen expressed in human breast tumors. The NGcGM3/VSSP vaccine, consisting in very small-sized proteoliposomes (VSSP) obtained by the incorporation of NGcGM3 into the outer membrane protein complex of Neisseria meningitidis, has been previously tested in a P...
Autores principales: | de la Torre, Ana, Pérez, Kirenia, Vega, Aliz M., Santiesteban, Eduardo, Ruiz, Raiza, Hernández, Leonardo, Durrutí, Dayamí, Viada, Carmen E., Sánchez, Liset, Álvarez, Mabel, Durán, Yunier, Moreno, Yoisbel G., Arencibia, Maylén, Cepeda, Meylán, Domecq, Milagros, Cabrera, Leticia, Sánchez, Jorge L., Hernández, José J., Valls, Ana R., Fernández, Luis E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760670/ https://www.ncbi.nlm.nih.gov/pubmed/26917965 http://dx.doi.org/10.4137/BCBCR.S32785 |
Ejemplares similares
-
NGcGM3 Ganglioside: A Privileged Target for Cancer Vaccines
por: Fernandez, Luis E., et al.
Publicado: (2010) -
Effect of vaccination with N-glycolyl GM3/VSSP vaccine by subcutaneous injection in patients with advanced cutaneous melanoma
por: Osorio, Marta, et al.
Publicado: (2012) -
NGlycolylGM3/VSSP Vaccine in Metastatic Breast Cancer Patients: Results of Phase I/IIa Clinical Trial
por: de la Torre, Ana, et al.
Publicado: (2012) -
CAR T cells targeting the ganglioside NGcGM3 control ovarian tumors in the absence of toxicity against healthy tissues
por: Cribioli, Elisabetta, et al.
Publicado: (2022) -
Synergistic potentiation of the anti-metastatic effect of anti EGFR mAb by its combination with immunotherapies targeting the ganglioside NGcGM3
por: Palomo, Addys González, et al.
Publicado: (2018)